Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications
Frontiers in Pharmacology · 12.11.2024 · 15
DOI: 10.3389/fphar.2024.1442888 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.11.2024. Verfasst von Cigir Biray Avci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Türkiye. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The tumor microenvironment (TME) plays a crucial role in cancer development and metastasis. This review summarizes the current research on how the TME promotes metastasis through molecular pathways, focusing on key components, such as cancer-associated fibroblasts, immune cells, endothelial cells, cytokines, and the extracellular matrix. Significant findings have highlighted that alterations in cellular communication within the TME enable tumor cells to evade immune surveillance, survive, and invade other tissues. This review highlights the roles of TGF-β and VEGF signaling in promoting angiogenesis and extracellular matrix remodeling, which facilitate metastasis. Additionally, we explored how metabolic reprogramming of tumor and stromal cells, influenced by nutrient availability in the TME, drives cancer progression. This study also evaluated the therapeutic strategies targeting these interactions to disrupt metastasis. By providing a multidisciplinary perspective, this study suggests that understanding the molecular basis of the TME can lead to more effective cancer therapies and identify potential avenues for future research. Future research on the TME should prioritize unraveling the molecular and cellular interactions within this complex environment, which could lead to novel therapeutic strategies and personalized cancer treatments. Moreover, advancements in technologies such as single-cell analysis, spatial transcriptomics, and epigenetic profiling offer promising avenues for identifying new therapeutic targets and improving the efficacy of immunotherapies, particularly in the context of metastasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Adnan Menderes University, Aydin, Türkiye.
- Department of Neurology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran.
- Student Research Committee, Khoy University of Medical Sciences, Khoy, Iran.
Zitieren
APA
Biray Avci, C., Goker Bagca, B., Nikanfar, M., Takanlou, L. S., Takanlou, M. S., & Nourazarian, A. (2024). Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1442888
Vancouver
Biray Avci C, Goker Bagca B, Nikanfar M, Takanlou LS, Takanlou MS, Nourazarian A. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1442888
BibTeX
@article{BirayAvci2024,
author = {Biray Avci, Cigir and Goker Bagca, Bakiye and Nikanfar, Masoud and Takanlou, Leila Sabour and Takanlou, Maryam Sabour and Nourazarian, Alireza},
title = {Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1442888}
}
EUVIMED